Table 3.
Proportion of treated comorbidities in axial spondyloarthritis patients (N = 1776)
| Comorbidity | Percent diagnosed | Percent treated |
|---|---|---|
| Hypertension without complications | 44.4 | 87.1 |
| Beta-blockers (ATC code C07) | 49.8 | |
| ACE inhibitors (ATC codes C09AA, C09B) | 37.5 | |
| Angiotensin-I-antagonists (ATC codes C09CA, C09D) | 34.8 | |
| Diuretic drugs (ATC code C03) | 22.7 | |
| Hypertension with complications | 7.2 | 98.3 |
| Beta-blockers (ATC code C07) | 66.0 | |
| ACE inhibitors (ATC codes C09AA, C09B) | 37.5 | |
| Angiotensin-I-antagonists (ATC codes C09CA, C09D) | 49.2 | |
| Diuretic drugs (ATC code C03) | 45.5 | |
| Depression | 25.6 | 46.7 |
| Anti-depressants (ATC code N06A) | 46.7 | |
| Chronic pulmonary disease | 23.4 | 46.9 |
| LABA (ATC codes R03AC, R03AK, R03AL) | 41.0 | |
| LAMA (ATC code R03BB) | 9.6 | |
| Inhaled corticosteroids (ATC code R03BA) | 13.2 | |
| Diabetes with complications | 8.7 | 77.4 |
| Insulin (ATC code A10A) | 32.6 | |
| Oral hypoglycaemics (ATC code A10B) | 60.1 | |
| Diabetes without complications | 7.3 | 44.4 |
| Insulin (ATC code A10A) | 12.4 | |
| Oral hypoglycaemics (ATC code A10B) | 38.6 | |
| Cardiac arrhythmias | 14.2 | 68.5 |
| Beta-blockers (ATC code C07) | 65.9 | |
| Digitalis glycosides (ATC code C01AA) | 5.7 | |
| Anti-arrhythmic drugs (ATC code C01BD) | 3.8 | |
| Peripheral vascular disorders | 8.7 | 63.0 |
| Antiplatelet drugs (ATC code B01AC) | 26.5 | |
| Heparin (−derivates) (ATC code B01AA) | 12.3 | |
| Vitamin K antagonists (ATC code B01AB) | 11.4 | |
| Statins (ATC code C10AA) | 44.2 | |
| Valvular disease | 8.1 | 73.7 |
| Beta-blockers (ATC code C07) | 62.0 | |
| ACE inhibitors (ATC codes C09AA, C09B) | 35.0 | |
| Diuretic drugs (ATC code C03) | 28.5 | |
| Congestive heart failure | 5.7 | 92.5 |
| Beta-blockers (ATC code C07) | 69.2 | |
| ACE inhibitors (ATC codes C09AA, C09B) | 40.2 | |
| Angiotensin-I-antagonists (ATC codes C09CA, C09D) | 36.9 | |
| Digitalis glycosides (ATC code C01AA) | 9.4 | |
| Diuretic drugs (ATC code C03) | 53.0 | |
| Fibromyalgia | 4.4 | 19.7 |
| Duloxetine (ATC code N06AX21) | 5.0 | |
| Pregabalin (ATC code N03AX16) | 9.5 | |
| Gabapentin (ATC code N03AX12) | 5.2 |
ACE angiotensin-converting-enzyme, LABA long-acting beta2 agonists, LAMA long-acting muscarinic antagonists